Overview

Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort

Status:
Completed

Trial end date:
2009-07-20

Target enrollment:

Participant gender:

Summary

In contrast with Hyoscine Butylbromide Capsule 10mg, Study is to evaluate the efficacy and safety of Hyoscine Butylbromide tablets 10 mg (20mg, 3 times daily, orally) over a period of 3 days for the treatment of occasional or recurrent episodes of self-reported gastric or intestinal spasm-like pain or discomfort

Phase:

Phase 3

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide